IP Library › Granted Patent US 9,266,962
Granted Patent B2
US 9,266,962 · App. 14/112,108 · Granted Feb 23, 2016

Amino acid sequence presenting fusion polypeptide and its use

Inventors: Herbert Andres (Penzberg, DE); David Casagolda Vallribera (Penzberg, DE); Hartmut Duefel (Schlehdorf, DE); Michael Gerg (Munich, DE); Christian Scholz (Penzberg, DE); Michael Schraeml (Penzberg, DE)
Assignee: Hoffman-La Roche Inc.
C07K16/40C07K16/1203C07K16/22C12N9/90G01N33/573G01N33/74C07K2317/92C07K2319/00C07K2319/21C07K2319/22C07K2319/23C07K2319/24C07K2319/35C07K2319/41C07K2319/43
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,266,962
App. No.
14/112,108
Granted
Feb 23, 2016
Kind
B2
Abstract

Herein is reported a fusion polypeptide according to formula (I): NH 2 —S 2 —X 1 —S 1 —COOH, wherein X 1 comprises either a random amino acid sequence or an amino acid sequence derived from a first polypeptide, S2 and S1 are non-overlapping amino acid sequences derived from a second polypeptide, and denotes a peptide bond, wherein the second polypeptide is a polypeptide with peptidyl-prolyl cis/trans-isomerase activity (PPIase activity) or is derived from the FKBP-fold domain family, wherein X 1 is inserted in place of the insert-in-flap-domain of the second polypeptide.

Claims (9)

1. A method for eliciting an immune response in an experimental animal against a polypeptide said method comprising: administering to the experimental animal a fusion polypeptide for at least one time, said fusion polypeptide comprising a polypeptide according to formula I:

NH 2 —S 2 —X 1 —S 1 —COOH  (formula I),

wherein:

X 1 comprises a random amino acid sequence or an amino acid sequence derived from a first polypeptide,

S 2 and S 1 are non-overlapping amino acid sequences derived from a second polypeptide, and

denotes a peptide bond,

wherein the second polypeptide is selected from the group consisting of human FKBP12, Arabidopsis thaliana FKBP13, Thermus thermophilus SlyD, Escherichia coli SlyD and Thermococcus gammatolerans SlyD, and

wherein X 1 is inserted in place of the insert-in-flap-domain (IF-domain) of the second polypeptide, and

wherein X 1 is the amino acid sequence of the polypeptide.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 17, 2014
From: ROCHE DIAGNOSTICS GMBH
To: F. HOFFMANN-LA ROCHE AG
Reel/Frame 032698/0786 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 17, 2014
From: ANDRES, HERBERT; VALLRIBERA, DAVID CASAGOLDA; DUEFEL, HARTMUT; GERG, MICHAEL; SCHOLZ, CHRISTIAN; SCHRAEML, MICHAEL
To: ROCHE DIAGNOSTICS GMBH
Reel/Frame 032711/0630 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 17, 2014
From: ANDRES, HERBERT; VALLRIBERA, DAVID CASAGOLDA; DUEFEL, HARTMUT; GERG, MICHAEL; SCHOLZ, CHRISTIAN; SCHRAEML, MICHAEL
To: ROCHE DIAGNOSTICS GMBH
Reel/Frame 032712/0336 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 17, 2014
From: ROCHE DIAGNOSTICS GMBH
To: F. HOFFMANN-LA ROCHE AG
Reel/Frame 032712/0453 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 17, 2014
From: F. HOFFMANN-LA ROCHE AG
To: HOFFMANN-LA ROCHE INC.
Reel/Frame 032712/0508 →
Continuity (1)
Related Publication 20140178393A1 · Jun 26, 2014